Core Viewpoint - Future Health Technology Co., Ltd. is preparing for an IPO in Hong Kong, aiming to raise funds for enhancing its health technology R&D capabilities, brand building, and multi-channel marketing [1][11]. Company Overview - Future Health is a leading company in the smart wearable health device sector in China, known for its massage device brand "SKG" [1][2]. - The company has focused on smart wearable health devices since 2016, utilizing medical-grade technologies such as medium-frequency pulse and transcutaneous electrical nerve stimulation (TENS) [2]. Financial Performance - For the first three quarters of 2025, the company reported a profit of 106 million yuan, with a revenue of 878 million yuan, reflecting a year-on-year growth of 16.22% in revenue and 24.92% in profit [5]. - The company’s revenue for the years 2022, 2023, and 2024 was 904 million yuan, 1.046 billion yuan, and 1.045 billion yuan respectively, with corresponding profits of 119 million yuan, 127 million yuan, and 135 million yuan [4]. Product Segmentation - The core product, neck and shoulder relief wearable devices, accounted for over 40% of revenue but saw a decline in revenue by 1.85% year-on-year in the first three quarters of 2025, generating 385 million yuan [6]. - Revenue from fitness recovery and shaping devices surged by 122.8% year-on-year, reaching 200 million yuan, increasing its revenue share to 23% [6]. R&D and Marketing Expenditure - R&D expenditure as a percentage of revenue decreased from 9.1% in 2022 to 6.6% in the first three quarters of 2025, while sales and marketing expenses increased from 18.2% to 22.6% during the same period [8]. Dividend Distribution - The company has a history of high dividend payouts, distributing 199 million yuan to shareholders in the first nine months of 2025, following previous distributions of 50 million yuan and 30 million yuan in 2022 and 2023 respectively [11].

Core Viewpoint - SKG, a popular massage device brand endorsed by celebrity Wang Yibo, is attempting to go public on the Hong Kong Stock Exchange after previous unsuccessful attempts. The company faces scrutiny over its heavy marketing expenditures, low R&D investment, and significant cash dividends paid to its controlling shareholders before the IPO [1][31]. Group 1: Company Background and Market Position - Founded in 2007 by Liu Jie, SKG initially targeted the white goods market before pivoting to wearable massage devices in 2016, achieving significant online popularity with its neck massager [3][32]. - SKG's product range includes smart wearable relaxation devices, sports recovery products, smart health watches, and health home products [4][32]. - By 2024, SKG is projected to hold a 21.5% market share in China's smart wearable relaxation device sector, leading the industry [7][36]. Group 2: Financial Performance - SKG's revenue has shown growth, with figures of 904.2 million, 1.045 billion, and 1.045 billion RMB for 2022, 2023, and 2024 respectively, and 878.2 million RMB for the first three quarters of 2025. Net profits for the same periods were 119.3 million, 126.5 million, 135.5 million, and 106.4 million RMB [8][36]. - The company's gross margin stands at approximately 50%, which is higher than that of typical home appliance manufacturers [6][34]. Group 3: Marketing and R&D Expenditures - Since 2020, SKG has invested heavily in marketing, spending around 800 million RMB over three and a half years, while R&D expenditures have been significantly lower, totaling less than 80 million RMB [41][45]. - Marketing expenses have increased, constituting 18.2%, 20.6%, 21.6%, and 22.6% of total revenue from 2022 to the first three quarters of 2025, while R&D spending has decreased as a percentage of revenue [16][45]. Group 4: Dividend Practices and Financial Concerns - SKG has distributed a total of 280 million RMB in dividends from 2022 to September 2025, representing 74% of its net profits during that period. In 2023 alone, the company paid out 199.4 million RMB in dividends, exceeding its distributable profits [24][52]. - The controlling shareholders, Liu Jie and Xu Siying, received approximately 235 million RMB from these dividends, raising concerns about the company's financial health as it also increased its bank loans from 94 million to 204 million RMB during the same period [28][56].

Core Viewpoint - The company Future Health is attempting to go public on the Hong Kong Stock Exchange after unsuccessful attempts to list on the A-share market, highlighting concerns over its marketing-heavy strategy and low R&D investment [1][2]. Group 1: Company Performance - Future Health has shown steady net profit growth over the past three years, with high gross margins around 50%, significantly exceeding typical household appliance margins [1][5]. - The company's revenue for 2022, 2023, and 2024 is reported at 904 million, 1.046 billion, and 1.045 billion respectively, with net profits of 119 million, 127 million, and 135 million [2]. - In the first nine months of 2025, the company achieved a revenue of 878 million and a net profit of 106 million [2]. Group 2: Marketing and R&D Strategy - Future Health's marketing expenses have increased, accounting for 22.6% of revenue, while R&D investment has decreased to 6.6% [1][7]. - The company relies heavily on online sales channels, which contributed 60.2% of its revenue in 2022, decreasing to 49.3% by 2025 [6]. - The company employs various marketing strategies, including celebrity endorsements and social media engagement, with marketing expenses rising from 1.64 billion in 2022 to 1.98 billion in the first nine months of 2025 [6][7]. Group 3: Financial Practices and Concerns - Future Health has distributed a total of 280 million in dividends prior to its IPO, raising concerns about its financial practices, especially as it simultaneously increased its debt from 94 million to 204 million [8]. - The company's ownership structure is heavily concentrated, with the founders controlling over 85% of the voting rights, leading to questions about governance and financial transparency [8]. Group 4: Industry Context - The wearable health device market in China is projected to grow from 30.9 billion in 2019 to 61.5 billion by 2024, with a compound annual growth rate of 15.9% expected from 2024 to 2029 [3]. - Future Health is positioned as a leader in the smart wearable health device sector, holding a 21.5% market share in 2024 [2]. - The competitive landscape is characterized by a focus on technology and market segmentation, with leading companies holding over 25% of the market share [4].